IP Library Granted Patent US 9,102,943
Granted Patent B2
US 9,102,943 · App. 13/823,805 · Granted Aug 11, 2015

Method for producing virus vector

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,102,943
App. No.
13/823,805
Granted
Aug 11, 2015
Kind
B2
Abstract

The present invention provides a method for producing a virus vector, which comprises a step wherein cells that are capable of producing a virus vector are cultured in a culture medium that contains, as active components, a retinoic acid and a histone deacetylase inhibiting substance; and a culture medium for the production of a virus vector, which is characterized by containing, as active components, a retinoic acid and a histone deacetylase inhibiting substance.

Claims (9)

1. A method of producing a retrovirus particle, which comprises a step of culturing a producer cell line which produces the retrovirus particle and producing the retrovirus particle in a culture medium containing retinoic acid and a histone deacetylase inhibitor as active ingredients and a step of harvesting a supernatant containing the retrovirus particle from the culture medium,

wherein the culture medium contains either 100 nM to 3 μM trichostatin A or 1 mM to 10 mM sodium butyrate as the histone deacetylase inhibitor, and

wherein the method provides retrovirus particles having higher gene transduction efficiency as compared to culture conditions not comprising retinoic acid and a histone deacetylase inhibitor.

2. The method according to claim 1 , wherein the culture medium further contains lipid as an active ingredient.

3. The method according to claim 1 , wherein the producer cell line stably produces the retrovirus particle.

4. A method of producing a transformed cell population, which comprises a step of producing a retrovirus vector by the method according to claim 1 , and a step of transforming a cell with the retrovirus vector produced in the above step.

5. The method according to claim 3 , wherein the producer cell line is prepared by transfecting a nucleic acid encoding a retrovirus vector into packaging cell line PG13.

6. The method according to claim 1 , wherein the culture medium contains 5 nM to 200 nM all-trans retinoic acid as the retinoic acid.

7. The method according to claim 1 , wherein the culture medium further contains dexamethasone as an active ingredient.

Assignments (2)
CHANGE OF ADDRESS Recorded Jun 24, 2016
From: TAKARA BIO INC.
To: TAKARA BIO INC.
Reel/Frame 039152/0834 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2013
From: SHINMURA, KAZUHISA; KATAYAMA, YOSHINORI; SAKAI, KENSUKE; SHODAI, TOSHIHIRO; YOSHIOKA, HIROFUMI; MINENO, JUNICHI
To: TAKARA BIO INC.
Reel/Frame 030011/0013 →